par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • March 13th, 2018 • Newlink Genetics Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2018 Company Industry JurisdictionNewLink Genetics Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: